Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-24 @ 6:47 PM
NCT ID:
NCT00517257
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 40 years and older
* Diagnosed with CRVO or BRVO
* Visual acuity of 20/40 or worse in the affected eye
* Onset of current symptoms of loss of vision within the past 60 days
* Ability to understand spoken English
Exclusion Criteria:
* Current use of a statin or fibrate medication
* Known cardiovascular disease or revascularization, including coronary artery disease (myocardial infarction or angina), stroke or peripheral artery occlusion
* Known diabetes mellitus
* Known liver disease
* Serum low-density lipoprotein cholesterol (LDL-C) \> 5.0 mmol/L
* Baseline serum triglycerides \> 6.0 mmol/L
* Serum ALT above 115 U/L (i.e., 2.5 x upper limit of normal)
* Baseline serum creatinine \> 250 µmol/L
* Ocular surgery within the past 90 days
* Planned ocular or cataract surgery within the study period
* Known retinal disease: age-related macular degeneration, retinal detachment or macular hole, or past history of vein occlusion
* Women who are pregnant or who are breastfeeding
* Participation in another clinical trial concurrently or within 30 days prior to screening
* Known allergy to fluorescein dye
* Current use of cyclosporine medication.
* Current use of an HIV protease inhibitor medication.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT00517257
Study Brief:
Protocol Section:
NCT00517257